Lupus Erythematosus News and Research

RSS

Video game intervention improves attention and executive functioning in patients with lupus

A National Jewish Health led study recently published in Lupus finds that technology through video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

14 Jul 2022

The global succinylation and protein abundance in SARS-CoV-2–infected cells

Researchers assessed the global succinylation of SARS-CoV-2-infected host cells.

14 Jul 2022

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

People with systemic lupus erythematosus, or SLE, who received a "booster" dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent "breakthrough" COVID-19 infection, a new study shows.

13 Jul 2022

Novel molecular pathway may explain how stress affects neuropsychiatric lupus

A novel molecular pathway involving cell signaling proteins in the brain may explain how stress affects neuropsychiatric lupus with diffuse neuropsychological manifestations.

11 Jul 2022

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

In a recent review published in Immunity, researchers explored potential mechanisms of neuro-immune pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Jun 2022

Multidisciplinary medical team needed to provide care for pregnant women with lupus, study says

A study that includes researchers at Hospital for Special Surgery underscores the importance of a multidisciplinary medical team to counsel and provide care for women with systemic lupus erythematosus, the most common form of lupus, who become pregnant.

2 Jun 2022

New HSS study clarifies the clinical manifestations of undifferentiated connective tissue disease

A new study by researchers at Hospital for Special Surgery (HSS) has further clarified the clinical manifestations of undifferentiated connective tissue disease (UCTD).

2 Jun 2022

UH expert in lupus reports two new discoveries

Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and heart, are being reported in scientific and medical journals.

2 Jun 2022

Report highlights the need for an office to support autoimmune disease research across NIH institutes

While the quantity and quality of research that the National Institutes of Health (NIH) conducts on autoimmune diseases is impressive, a strategic plan and a well-funded office to support the coordination of all autoimmune disease research across NIH institutes and centers are needed, says a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine.

10 May 2022

Elevated and sustained autoantibodies following COVID-19

A new study demonstrated that autoantibody levels rise following acute SARS-CoV-2 infection and remain to be elevated for about six months.

10 May 2022

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).

6 May 2022

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

NYU Langone Health is joining a new National Institutes of Health (NIH)-sponsored program called Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) as a leading center to discover new targets for therapy in these diseases.

30 Mar 2022

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Long term exposure to air pollution is linked to a heightened risk of autoimmune disease, particularly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, finds research published online in the open access journal RMD Open.

16 Mar 2022

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

28 Feb 2022

EULAR develops new recommendations for cardiovascular risk management

EULAR, the European Alliance of Associations for Rheumatology, has developed new recommendations for CVR management in people with gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren's syndrome (SS), systemic lupus erythematosus (SLE), and antiphospholipid syndrome (APS).

23 Feb 2022

Lupus Erythematosus News and Research

Video game intervention improves attention and executive functioning in patients with lupus

The global succinylation and protein abundance in SARS-CoV-2–infected cells

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

Novel molecular pathway may explain how stress affects neuropsychiatric lupus

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

Multidisciplinary medical team needed to provide care for pregnant women with lupus, study says

New HSS study clarifies the clinical manifestations of undifferentiated connective tissue disease

UH expert in lupus reports two new discoveries

Report highlights the need for an office to support autoimmune disease research across NIH institutes

Elevated and sustained autoantibodies following COVID-19

NIH launches clinical study to evaluate an investigational preventative vaccine for Epstein-Barr virus

NYU Langone joins NIH-sponsored program as leading center to discover new targets for autoimmune, inflammatory diseases

Research finds link between long-term exposure to air pollution and autoimmune disease risk

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

EULAR develops new recommendations for cardiovascular risk management

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

New, more accurate tool to measure the progress of lupus in patients

Transplant recipients benefit from a COVID-19 vaccine booster

Impact of mRNA-1273 vaccination during early pregnancy

LMU immunologists reveal how Roquin-1 controls the activity of immune cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News